On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Gerard Sanacora

ResearcherPublications, citations & collaboration network

Gerard Sanacora is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Gerard Sanacora have?

ScholarIQindexed works

Gerard Sanacora has 277 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Gerard Sanacora have?

ScholarIQcitation count

Gerard Sanacora has 34,534 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Gerard Sanacora?

ScholarIQh-index

Gerard Sanacora has an h-index of 86 in OpenAlex.

What is the i10-index of Gerard Sanacora?

ScholarIQi10-index

Gerard Sanacora has an i10-index of 179 in OpenAlex.

What is the ORCID of Gerard Sanacora?

ScholarIQorcid

The ORCID for Gerard Sanacora is on the source record.

What is the OpenAlex record for Gerard Sanacora?

ScholarIQopenalex

The OpenAlex for Gerard Sanacora is on the source record.

What are the most-cited papers on Gerard Sanacora?

ScholarIQmost cited works
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso, Jaskaran Singh, Maggie Fedgchin, Larry Alphs, Rosanne Lane, Pilar Lim, Christine Pinter, David Hough, Gerard Sanacora, Husseini K. Manji, Wayne C. Drevets
American Journal of Psychiatry. 2018669 CitationsOPEN ACCESS
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran Singh, Maggie Fedgchin, Ella Daly, Peter de Boer, Kimberly Cooper, Pilar Lim, Christine Pinter, James W. Murrough, Gerard Sanacora, Richard C. Shelton, Benji T. Kurian, Andrew Winokur, Maurizio Fava, Husseini K. Manji, Wayne C. Drevets, Luc Van Nueten
American Journal of Psychiatry. 2016530 CitationsOPEN ACCESS
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3
Rachel Ochs-Ross, Ella Daly, Yun Zhang, Rosanne Lane, Pilar Lim, Randall L. Morrison, David Hough, Husseini K. Manji, Wayne C. Drevets, Gerard Sanacora, David C. Steffens, Caleb M. Adler, Rupert McShane, Raphaël Gaillard, Samuel T. Wilkinson, Jaskaran Singh
American Journal of Geriatric Psychiatry. 2019477 CitationsOPEN ACCESS
Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent
Dong‐Jing Fu, Dawn F. Ionescu, Xiang Li, Rosanne Lane, Pilar Lim, Gerard Sanacora, David Hough, Husseini K. Manji, Wayne C. Drevets, Carla M. Canuso
The Journal of Clinical Psychiatry. 2020370 CitationsOPEN ACCESS
Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial
Vladimir Coric, Sarper Taşkıran, Christopher Pittenger, Suzanne Wasylink, Daniel H. Mathalon, Gerald Valentine, John R. Saksa, Yu‐Te Wu, Ralitza Gueorguieva, Gerard Sanacora, Robert T. Malison, John H. Krystal
Biological Psychiatry. 2005314 Citations

Related on ScholarIQ

470M+ articles · free account